227 related articles for article (PubMed ID: 15557205)
1. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease.
Kerfoot SM; Long EM; Hickey MJ; Andonegui G; Lapointe BM; Zanardo RC; Bonder C; James WG; Robbins SM; Kubes P
J Immunol; 2004 Dec; 173(11):7070-7. PubMed ID: 15557205
[TBL] [Abstract][Full Text] [Related]
2. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis.
Kerfoot SM; Kubes P
J Immunol; 2002 Jul; 169(2):1000-6. PubMed ID: 12097407
[TBL] [Abstract][Full Text] [Related]
3. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice.
James WG; Bullard DC; Hickey MJ
J Immunol; 2003 Jan; 170(1):520-7. PubMed ID: 12496439
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals.
Su SB; Silver PB; Zhang M; Chan CC; Caspi RR
J Immunol; 2001 Jul; 167(1):250-6. PubMed ID: 11418656
[TBL] [Abstract][Full Text] [Related]
5. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice.
Döring A; Wild M; Vestweber D; Deutsch U; Engelhardt B
J Immunol; 2007 Dec; 179(12):8470-9. PubMed ID: 18056394
[TBL] [Abstract][Full Text] [Related]
6. Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII.
Piccio L; Rossi B; Colantonio L; Grenningloh R; Gho A; Ottoboni L; Homeister JW; Scarpini E; Martinello M; Laudanna C; D'Ambrosio D; Lowe JB; Constantin G
J Immunol; 2005 May; 174(9):5805-13. PubMed ID: 15843584
[TBL] [Abstract][Full Text] [Related]
7. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice.
Engelhardt B; Kempe B; Merfeld-Clauss S; Laschinger M; Furie B; Wild MK; Vestweber D
J Immunol; 2005 Jul; 175(2):1267-75. PubMed ID: 16002731
[TBL] [Abstract][Full Text] [Related]
8. The Innate Immune Receptor CD14 Mediates Lymphocyte Migration in EAE.
Halmer R; Davies L; Liu Y; Fassbender K; Walter S
Cell Physiol Biochem; 2015; 37(1):269-75. PubMed ID: 26302995
[TBL] [Abstract][Full Text] [Related]
9. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide.
Zhou H; Lapointe BM; Clark SR; Zbytnuik L; Kubes P
J Immunol; 2006 Dec; 177(11):8103-10. PubMed ID: 17114485
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors.
Piccio L; Rossi B; Scarpini E; Laudanna C; Giagulli C; Issekutz AC; Vestweber D; Butcher EC; Constantin G
J Immunol; 2002 Feb; 168(4):1940-9. PubMed ID: 11823530
[TBL] [Abstract][Full Text] [Related]
11. Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model.
Yin JX; Tu JL; Lin HJ; Shi FD; Liu RL; Zhao CB; Coons SW; Kuniyoshi S; Shi J
PLoS One; 2010 Aug; 5(8):e12400. PubMed ID: 20811645
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels.
Andonegui G; Goyert SM; Kubes P
J Immunol; 2002 Aug; 169(4):2111-9. PubMed ID: 12165539
[TBL] [Abstract][Full Text] [Related]
13. PTX cruiser: driving autoimmunity via TLR4.
Racke MK; Hu W; Lovett-Racke AE
Trends Immunol; 2005 Jun; 26(6):289-91. PubMed ID: 15922942
[TBL] [Abstract][Full Text] [Related]
14. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient.
Phares TW; Fabis MJ; Brimer CM; Kean RB; Hooper DC
J Immunol; 2007 Jun; 178(11):7334-43. PubMed ID: 17513784
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.
Brocke S; Piercy C; Steinman L; Weissman IL; Veromaa T
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6896-901. PubMed ID: 10359810
[TBL] [Abstract][Full Text] [Related]
16. DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
Minten C; Alt C; Gentner M; Frei E; Deutsch U; Lyck R; Schaeren-Wiemers N; Rot A; Engelhardt B
Brain; 2014 May; 137(Pt 5):1454-69. PubMed ID: 24625696
[TBL] [Abstract][Full Text] [Related]
17. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.
McCandless EE; Wang Q; Woerner BM; Harper JM; Klein RS
J Immunol; 2006 Dec; 177(11):8053-64. PubMed ID: 17114479
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
[TBL] [Abstract][Full Text] [Related]
19. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity.
Kean RB; Spitsin SV; Mikheeva T; Scott GS; Hooper DC
J Immunol; 2000 Dec; 165(11):6511-8. PubMed ID: 11086092
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis.
Kerfoot SM; Norman MU; Lapointe BM; Bonder CS; Zbytnuik L; Kubes P
J Immunol; 2006 May; 176(10):6225-34. PubMed ID: 16670333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
